33 results
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... agent • Does not cause ... side effects (e.g ... #Metformin #Pharmacology ... #Summary #DM2 #
Common sodium channel blockers which cause QRS widening.

Anticonvulsants: 
 - Carbamazepine 
Antidysrhythmics:  
 - Group
blockers which cause ... QRS #widening #ECG ... #EKG #Pharmacology ... Differential #Drugs #Classes
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... Weight loss (~2-3kg ... mL/minute/1.73 m2 ... SGLT2 #Inhibitors #Pharmacology ... #Summary #DM2 #
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... side effects (e.g ... not definitively cause ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #
Vasopressors and Inotropes - Pharmacology Summary
Vasopressors
Phenylephrine (alpha-1)
 • Increases BP, SVR
 • Risk of reflex bradycardia
and Inotropes - Pharmacology ... • Higher doses cause ... • D1 (1-2 mcg/kg ... cAMP/cGMP • Causes ... Vasopressors #Inotropes #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... 0.3-0.6 units/kg ... Diabetes #Mellitus #DM2 ... #Medications #pharmacology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... not definitively cause ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 #
Isocoria - Pupillary Defects - Differential Diagnosis Algorithm
Relative Afferent Pupil Defect
 • Optic Neuritis
 • Ischemic
dissociation) • Pharmacologic ... (e.g Opioids, Alcohol ... • Botulism Pharmacologic ... Diagnosis #Algorithm #Causes
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
kidney), which causes ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2
Hydroxychloroquine Serum Measurement in SLE
 • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
suspected) • In case ... • Special cases ... (e.g. renal failure ... #rheumatology #pharmacology